The purpose of this study is to evaluate the efficacy and safety of etoricoxib compared to placebo in the treatment of postoperative pain associated with total abdominal hysterectomy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
430
120 mg of etoricoxib (MK0663) for a total of 5 days
Placebo tablets once daily on Days 1-5. Total treatment is 5 days.
90 mg of etoricoxib (MK0663) for a total of 5 days
Average Pain Intensity at Rest Over Days 1 to 3
Pain intensity at rest was measured on a 0- to 10-point scale: 0=no pain, to 10=pain as bad as you can imagine.
Time frame: 3 Days
Average Total Daily Dose of Morphine Over Days 1 to 3
Time frame: 3 days
Average Elicited Pain Upon Sitting Over Days 1 to 3
Elicited pain upon sitting was measured on a 0- to 10-point scale: 0=no pain, to 10=pain as bad as you can imagine.
Time frame: 3 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.